Inositec AG

Inositec ag email format

Verified email-pattern data for Inositec Ag is currently limited. You can still use the company insights and contact sections below.
Inositec is pioneering the development of life-saving small molecule drugs based on inositol phosphate, a natural facilitator of diverse cellular functions. Using its broadly applicable InosituneTM technology to adjust the chemical and physical properties of inositol phosphate (IP6) analogs, Inositec is developing a novel class of drugs currently focusing on high-unmet medical needs related to calcification disorders. The lead compound INS-3001 is a cardiovascular calcification inhibitor in development for aortic valve stenosis. Inositec was founded in December 2015 based on the award-winning research of Dr. Mattias Ivarsson, Prof. Jean-Christophe Leroux and Prof. Bastien Castagner at ETH Zurich, Switzerland. Inositec was acquired by Vifor Pharma in 2021.

Company Details

Founded
-
Address
Technoparkstrasse 1, Zurich,zurich 8005,switzerland
Phone
41442710755
Email
in****@****tec.com
Industry
Pharmaceutical Manufacturing
Keywords
IPCAA.
HQ
Zurich, Zurich
Looking for a particular Inositec AG employee's phone or email?

Inositec Ag Questions

Explore related pages

Related company profiles:

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant